- Home
- TW vs PODD Comparison
TW vs PODD Comparison
Compare TW & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TW | PODD |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 21.0B |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TW | PODD |
|---|---|---|
| Price | $105.60 | $286.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 19 |
| Target Price | $141.17 | ★ $367.32 |
| AVG Volume (30 Days) | ★ 1.3M | 626.8K |
| Earning Date | 02-05-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.45% | N/A |
| EPS Growth | ★ 40.82 | N/A |
| EPS | 2.93 | ★ 3.45 |
| Revenue | $1,992,479,000.00 | ★ $2,521,800,000.00 |
| Revenue This Year | $22.61 | $32.55 |
| Revenue Next Year | $11.04 | $20.47 |
| P/E Ratio | ★ $36.27 | $83.37 |
| Revenue Growth | 22.37 | ★ 27.11 |
| 52 Week Low | $101.71 | $230.05 |
| 52 Week High | $152.65 | $354.88 |
Technical Indicators
Market Signals| Indicator | TW | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 44.53 |
| Support Level | $102.00 | $275.10 |
| Resistance Level | $111.89 | $299.80 |
| Average True Range (ATR) | 2.60 | 7.48 |
| MACD | -0.20 | 0.77 |
| Stochastic Oscillator | 36.01 | 45.07 |
Price Performance
Historical ComparisonAbout TW Tradeweb Markets Inc.
Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in US and European government debt, mortgage-backed securities, interest-rate swaps, and US and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.